Literature DB >> 12708809

CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions.

J Plumb1, M A Armstrong, M Duddy, M Mirakhur, S McQuaid.   

Abstract

Multiple sclerosis (MS) has a wide spectrum of clinical courses, characterized by multifocal central nervous system (CNS) damage, postulated to be mediated by CNS antigen-specific T cells. Dendritic cells (DC), the most potent antigen-presenting cell, play a pivotal role in the decision between T-cell activation or anergy. Monoclonal antibodies to CD1a (immature DC) and CD83 (mature DC) were used to screen lesions with evidence of recent demyelinating activity and chronic plaque and normal appearing white matter (NAWM) tissue sections from 12 MS cases by immunocytochemistry. No CD1a-positive cells were detected in the MS or control CNS tissue blocks investigated. CD83-positive cells were not detected in tissues from any of the control cases or in the majority of perivascular cuffs in the MS tissue sections. However; in eight of the MS tissue blocks with evidence of recent demyelination, and in one block each from chronic plaque and NAWM, small numbers of distinct CD83-positive cells were present within occasional perivascular cuffs. In one area only of MS NAWM were CD83-positive cells detected in the tissue parenchyma, in an area of intense immunological activity. DC in MS tissue may originate in the peripheral circulation as monocytes or immature DC and migrate to areas of plaque in response to signals received from CNS-produced chemokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12708809     DOI: 10.1191/1352458503ms890oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

Review 1.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans.

Authors:  D Brassat; A A Motsinger; S J Caillier; H A Erlich; K Walker; L L Steiner; B A C Cree; L F Barcellos; M A Pericak-Vance; S Schmidt; S Gregory; S L Hauser; J L Haines; J R Oksenberg; M D Ritchie
Journal:  Genes Immun       Date:  2006-04-20       Impact factor: 2.676

3.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

Review 4.  The role of dendritic cells in multiple sclerosis.

Authors:  Gregory F Wu; Terri M Laufer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

5.  Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis.

Authors:  Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Florin Niculescu; Katherine M Mullen; Sonia Vlaicu; Susan I V Judge; Peter A Calabresi; Horea Rus
Journal:  Exp Mol Pathol       Date:  2007-07-06       Impact factor: 3.362

6.  Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain.

Authors:  James F Curtin; Gwendalyn D King; Carlos Barcia; Chunyan Liu; François X Hubert; Carole Guillonneau; Régis Josien; Ignacio Anegon; Pedro R Lowenstein; Maria G Castro
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

7.  Modulation of dendritic cell development by immunoglobulin G in control subjects and multiple sclerosis patients.

Authors:  K Ohkuma; T Sasaki; S Kamei; S Okuda; H Nakano; T Hamamoto; K Fujihara; I Nakashima; T Misu; Y Itoyama
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

8.  Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis.

Authors:  Clara de Andrés; Roseta Teijeiro; Bárbara Alonso; Francisco Sánchez-Madrid; M Luisa Martínez; Juan Guzmán de Villoria; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

9.  Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.

Authors:  Jagannadha R Avasarala; Sridar V Chittur; Ajish D George; John A Tine
Journal:  BMC Med Genomics       Date:  2008-01-31       Impact factor: 3.063

10.  An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis.

Authors:  Naomi Tsurikisawa; Hiroshi Saito; Chiyako Oshikata; Takahiro Tsuburai; Miyako Ishiyama; Hiroyuki Mitomi; Kazuo Akiyama
Journal:  BMC Immunol       Date:  2014-08-31       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.